Leading medical organizations team up to bring new TB treatments to those in need
03/19/2015. International organizations Partners In Health (PIH), Médecins Sans Frontières (MSF), Interactive Research and Development (IRD) and their financial partner UNITAID will start in April the endTB project, a partnership aimed at radically changing the management of multidrug-resistant tuberculosis (MDR-TB).
By 2019, endTB will provide access to two new anti-TB drugs (bedaquiline and delamanid), for 2,600 MDR-TB patients in 16 countries. These are the first new anti-TB drugs developed in over 50 years and these drugs offer new hope to patients suffering from MDR-TB.
Read the article on MSF website
Related Articles
Malteser International gains Special Consultative status to the United Nations Economic and Social Council
06/07/2018. “This is a landmark achievement for us and our work for the most vulnerable people of this world”
Implementing a national strategy for the integration of Roma people in Hungary
04/07/2019. Miklos Vecsei C.G.M. vice-President of the Hungarian Charity Service of the Order, was recently appointed State Commissioner charged with coordinating the drafting and implementation of a diagnosis-based national strategy for the integration of Roma people.
UN aid officials urge Security Council to push for greater humanitarian access in Syria
01/26/2017. “We need to be allowed to pass – not as a favour but as a right – and safely.” he said.
